10-K/A: TruBridge Inc. Files Amended 10-K After Identifying Material Weakness in Internal Controls

TruBridge Inc. has filed an amended 10-K report to restate its internal control assessment due to a material weakness identified in financial reporting procedures.

Summary

• TruBridge, Inc. filed an amendment to its annual report on Form 10-K for the fiscal year ended December 31, 2023, due to a material weakness in internal control over financial reporting.
• The material weakness relates to procedures for processing customer contract changes, terminations, and issuing credits, which existed as of December 31, 2023, and continued through June 30, 2024.
• Management concluded that the company's internal control over financial reporting was not effective as of December 31, 2023.
• The company has been working to remediate the weakness by redesigning and implementing additional controls and procedures, enhancing communication, and evaluating technology and automation.
• Despite the material weakness, the company believes its consolidated financial statements present fairly its financial position, results of operations, and cash flows for the periods presented.
• The amendment includes restated management and auditor reports on internal control over financial reporting, and revised disclosures on the effectiveness of disclosure controls and procedures.
• The company had approximately $199.6 million in principal amount of indebtedness as of December 31, 2023, including $63.9 million under a term loan facility and $135.7 million borrowed under a revolving credit facility.

Sentiment

Score: 3

Explanation: The document reveals a significant internal control weakness and restatement of financials, which is a major negative. While the company is taking steps to remediate, the overall tone is concerning from an investment perspective.

Positives

• The company is actively working to remediate the identified material weakness in internal controls.
• Management believes the consolidated financial statements present fairly the company's financial position despite the material weakness.
• The company has seen a substantially diminished need for the issuance of customer credits as a result of remediation efforts.

Negatives

• A material weakness in internal control over financial reporting was identified.
• The company's disclosure controls and procedures were deemed not effective as of December 31, 2023.
• The company has a substantial amount of debt, which could impact its financial flexibility.
• The company recorded a significant goodwill impairment charge of $35.9 million in 2023.

Risks

• The company faces risks related to industry consolidation, which could lead to loss of clients and downward pressure on prices.
• Economic factors may cause a decline in spending for information technology and services by clients.
• The healthcare industry is subject to significant regulatory uncertainty, which could impact the company's business.
• Failure to comply with healthcare regulations could result in civil and criminal penalties.
• The company's strategy to transition to a subscription-based model may adversely affect near-term revenue growth.
• Competition from companies with greater resources could result in loss of clients and lower prices.
• Acquisitions may be expensive, time-consuming, and subject to integration risks.
• Failure to attract and retain qualified personnel could negatively impact the business.
• The company faces risks associated with litigation and investigations.
• Reliance on offshore labor resources could expose the company to risks.
• The company's use of artificial intelligence could expose it to liability.
• Failure to develop new products or enhance current products could adversely impact the company's competitive position.
• Breaches of security and viruses in the company's systems could result in client claims and harm to the company's reputation.
• The company's substantial indebtedness may adversely affect its available cash flow and ability to operate.
• The company is subject to changes in and interpretations of financial accounting matters.
• The company may be required to record additional significant charges to earnings if goodwill or intangible assets become impaired.
• The unpredictability of the company's quarterly operating results may cause the stock price to fluctuate.
• The company's common stock price has experienced significant volatility.
• The company's facilities are located in an area vulnerable to hurricanes and tropical storms.
• The company is exposed to market risk related to interest rate changes.
• Macroeconomic conditions could have a materially adverse impact on the company's business.

Future Outlook

The company will continue to devote time and attention to remediation efforts and may take additional measures to address the material weakness or modify the remediation plan.

Management Comments

• Management concluded that there was a deficiency in TruBridges internal control over financial reporting related to TruBridges procedures for processing customer contract changes and terminations and issuing credits to customers.
• Management believes that the consolidated financial statements included in the Original Filing present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented, in conformity with accounting principles generally accepted in the United States of America.
• The Companys management, under the leadership of the new Chief Financial Officer since January 1, 2024, has worked to strengthen the Companys internal controls and improve its procedures for processing customer contract changes and terminations and issuing credits to customers, including adding key personnel to the Companys finance team.

Industry Context

The healthcare industry is facing significant regulatory and economic pressures, which are impacting the company's clients and, consequently, the company itself. The company's focus on community hospitals, which often have higher uninsured populations and rely more heavily on Medicare and Medicaid, makes it particularly vulnerable to changes in reimbursement rates and healthcare legislation.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards, but it does mention several competitors in the business management, consulting, managed IT services, RCM solutions, acute EHR, and patient engagement markets.
• Competitors in the business management, consulting and managed IT services market include Resolution Health, Inc., The Outsource Group Inc., Patient Focus, Inc., Xtend Healthcare Inc., Ensemble Health Partners, and nThrive, Inc.
• Competitors for RCM solutions include RelayHealth Corp, SSI Group, LLC, Quadax Inc., Change Healthcare Holdings, Inc., Availity, LLC, and Navicure, Inc.
• TruCode's primary competitors include 3M, Nuance and Optum.
• Principal competitors in the acute EHR market are Cerner Corporation, Medical Information Technology, Inc. (Meditech), and MEDHOST, Inc.
• The company's performance should be evaluated against these competitors and industry benchmarks for financial performance, operational efficiency, and compliance with regulatory standards.

Stakeholder Impact

• Shareholders may experience a negative impact on the stock price due to the identified material weakness and restatement.
• Employees may be affected by the restructuring and remediation efforts.
• Customers may be concerned about the reliability of the company's financial reporting and internal controls.
• Creditors may be concerned about the company's ability to meet its debt obligations.

Next Steps

• The company will continue to evaluate and work to improve its internal control over financial reporting.
• Management may determine to take additional measures to address the material weakness or modify the remediation plan.

Key Dates

Keywords

internal control, financial reporting, material weakness, healthcare technology, revenue cycle management, EHR, debt, acquisitions, cybersecurity, regulatory compliance